Marina Corleto
Posts by Marina Corleto
Forge Biologics shares plans for growth at Meeting on the Med
Forge Biologics closed an additional $80M financing to accelerate the company’s planned CDMO expansion
Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord
Solid Biosciences, Forge Biologics Enter Development and Manufacturing Pact
EMA Orphan Drug Designation for Forge Biologics’ gene therapy for Krabbe disease
Forge Biologics to Present at Jefferies Virtual Healthcare Conference
COLUMBUS, OHIO June 1, 2021—Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced today that its CEO, President […]
Read More… from Forge Biologics to Present at Jefferies Virtual Healthcare Conference
Forge Biologics to Present at the ASGCT’s Annual Meeting
COLUMBUS, OHIO May 10, 2021 – Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced today that David […]
Read More… from Forge Biologics to Present at the ASGCT’s Annual Meeting